NCI Plans $10M for High Priority Small Business Grants | GenomeWeb

NEW YORK (GenomeWeb News) – The National Cancer Institute said on Monday that it plans to use $10 million to fund new research projects by small businesses that focus on specific high-priority areas where new devices and technologies are needed to support cancer diagnosis and treatment.

Funded under the Small Business Innovation Research (SBIR) program, the new grants will support projects to develop a range of technologies that are based on genomic, proteomic, and metabolomic discoveries, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.